| Year |
Title |
Altmetric |
| 2021
|
A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
Breast Cancer Research and Treatment.
187:777-784.
2021
|
|
| 2020
|
Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
Southern Medical Journal.
113:559-563.
2020
|
|
| 2019
|
Pathological complete response after neoadjuvant pembrolizumab and radiation.
Clinical and Experimental Dermatology.
44:570-573.
2019
|
|
| 2018
|
Molecular determinants of post-mastectomy breast cancer recurrence.
npj Breast Cancer.
4.
2018
|
|
| 2018
|
Breast Cancer Screening and Optimizing Recommendations.
Seminars in Roentgenology.
53:280-293.
2018
|
|
| 2018
|
Contrast-Enhanced Spectral Mammography in Breast Imaging.
Seminars in Roentgenology.
53:294-300.
2018
|
|
| 2018
|
High-Risk Breast Lesions and Current Management.
Seminars in Roentgenology.
53:252-260.
2018
|
|
| 2018
|
Post-mastectomy Radiation Yes but Internal Mammary Nodes No
2018
|
|
| 2018
|
A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors.
Cancer.
124:3427-3435.
2018
|
|
| 2018
|
The Evolving Role of Postmastectomy Radiation Therapy.
Surgical Clinics of North America.
98:801-817.
2018
|
|
| 2018
|
Pilot Randomized Controlled Trial of a Home Vegetable Gardening Intervention among Older Cancer Survivors Shows Feasibility, Satisfaction, and Promise in Improving Vegetable and Fruit Consumption, Reassurance of Worth, and the Trajectory of Central Adiposity.
Journal of the Academy of Nutrition and Dietetics.
118:689-704.
2018
|
|
| 2018
|
Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases.
Journal of Cutaneous Pathology.
45:48-53.
2018
|
|
| 2018
|
Innovations in Personalized and Targeted Therapies for Breast Cancer.
International Journal of Breast Cancer.
2018.
2018
|
|
| 2018
|
Postmastectomy Radiation Therapy: Are We Ready to Individualize Radiation?.
International Journal of Breast Cancer.
2018.
2018
|
|
| 2017
|
Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials.
Annals of Surgical Oncology.
24:2855-2862.
2017
|
|
| 2017
|
Eliminating Surgery in Early-Stage Breast Cancer: Pipe-Dream or Worthy Consideration in Selected Patients?.
Current Breast Cancer Reports.
9:148-155.
2017
|
|
| 2017
|
Attitudes of radiation oncologists toward palliative and supportive care in the United States: Report on national membership survey by the American Society for Radiation Oncology (ASTRO).
Practical Radiation Oncology.
7:113-119.
2017
|
|
| 2017
|
Complete response of mediastinal clear cell sarcoma to pembrolizumab with radiotherapy..
Clinical Sarcoma Research.
7:14.
2017
|
|
| 2016
|
Radiotherapy to Control Limited Melanoma Progression Following Ipilimumab.
Journal of Immunotherapy.
39:373-378.
2016
|
|
| 2016
|
Detailed methods of two home-based vegetable gardening intervention trials to improve diet, physical activity, and quality of life in two different populations of cancer survivors.
Contemporary Clinical Trials.
50:201-212.
2016
|
|
| 2016
|
US radiation oncology practice patterns for posttreatment survivor care.
Practical Radiation Oncology.
6:50-56.
2016
|
|
| 2015
|
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.
Practical Radiation Oncology.
5:e557-e565.
2015
|
|
| 2015
|
TBCRC 019: A phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple-negative breast cancer.
Clinical Cancer Research.
21:2722-2729.
2015
|
|
| 2015
|
Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
Breast Diseases.
26:239-241.
2015
|
|
| 2015
|
Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis: Mukesh MB, Barnett GC, Wilkinson JS, et al (Cambridge Univ Hosps Natl Health Service Foundation Trust, UK; Et al) J Clin Oncol 31:4488-4495, 2013.
Breast Diseases.
26:76-78.
2015
|
|
| 2015
|
Surgical Patterns of Care in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast Magnetic Resonance Imaging: Results of a Secondary Analysis of TBCRC 017.
Annals of Surgical Oncology.
22:75-81.
2015
|
|
| 2015
|
Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Breast Diseases.
26:243-245.
2015
|
|
| 2014
|
Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanoma
2014
|
|
| 2014
|
IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: Long term results of an ISIORT pooled analysis: Fastner G, Sedlmayer F, Merz F, et al (Paracelsus Med Univ, Salzburg, Austria; Et al) Radiother Oncol 108:279-286, 2013.
Breast Diseases.
25:170-171.
2014
|
|
| 2013
|
Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost: Chadha M, Woode R, Sillanpaa J, et al (Beth Israel Med Ctr, NY) Int J Radiat Oncol Biol Phys 86:40-44, 2013.
Breast Diseases.
24:386-388.
2013
|
|
| 2013
|
Multimodality therapy for high-risk endometrial cancer: Balancing the courses while keeping all options on the table
2013
|
|
| 2013
|
Image guided radiation therapy (IGRT) technologies for radiation therapy localization and delivery
2013
|
|
| 2013
|
MRI evaluation of neoadjuvant low-dose fractionated radiotherapy with concurrent chemotherapy in patients with locally advanced breast cancer: Bufi E, Belli P, Costantini M (Catholic Univ, Rome, Italy) Br J Radiol 85:e995-e1003, 2012.
Breast Diseases.
24:177-179.
2013
|
|
| 2013
|
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017.
Cancer.
119:1776-1783.
2013
|
|
| 2013
|
Accelerated partial breast irradiation for early-stage breast cancer: Controversies and current indications for use.
Current Treatment Options in Oncology.
14:51-65.
2013
|
|
| 2013
|
Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer; The university of alabama at birmingham experience.
International Journal of Gynecological Cancer.
23:559-566.
2013
|
|
| 2012
|
Ductal carcinoma in situ with microinvasion: Prognostic implications, long-term outcomes, and role of axillary evaluation.
Breast Diseases.
23:254-257.
2012
|
|
| 2012
|
Image-based 3D treatment planning for vaginal cylinder brachytherapy: Dosimetric effects of bladder filling on organs at risk
2012
|
|
| 2012
|
Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration: Gnerlich JL, Deshpande AD, Jeffe DB, et al (Washington Univ School of Medicine, St Louis, MO; Saint Louis Univ School of Public Health, MO) Ann Surg Oncol 18:1837-1844, 2011.
Breast Diseases.
23:138-140.
2012
|
|
| 2012
|
American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy.
Brachytherapy.
11:58-67.
2012
|
|
| 2012
|
American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer.
Brachytherapy.
11:68-75.
2012
|
|
| 2012
|
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy.
Brachytherapy.
11:47-52.
2012
|
|
| 2011
|
Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?: Daveau C, Savignoni A, Abrous-Anane S, et al (Institut Curie, Paris, France) Int J Radiat Oncol Biol Phys 79:1452-1459, 2011.
Breast Diseases.
22:402-404.
2011
|
|
| 2011
|
An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events..
Journal of Clinical Oncology.
29:121.
2011
|
|
| 2011
|
Precise correlation between MRI and histopathology - Exploring treatment margins for MRI-guided localized breast cancer therapy: Schmitz AC, van den Bosch MAAJ, Loo CE, et al (Antoni van Leeuwenhoek Hosp (NKI-AVL), Amsterdam, the Netherlands; Univ Med Ctr Utrecht, the Netherlands; et al) Radiother Oncol 97:225-232, 2010.
Breast Diseases.
22:204-205.
2011
|
|
| 2011
|
Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer..
Journal of Clinical Oncology.
29:e11048.
2011
|
|
| 2011
|
Nanoparticle-enhanced MRI to evaluate radiation delivery to the regional lymphatics for patients with breast cancer.
Breast Diseases.
22:74-75.
2011
|
|
| 2011
|
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer
2011
|
|
| 2011
|
Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy.
Clinical Breast Cancer.
11:312-319.
2011
|
|
| 2010
|
The importance and evolution of radiation dose in DCIS.
Current Cancer Therapy Reviews.
6:249-255.
2010
|
|
| 2010
|
Pilot trial of preoperative (Neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor-or progesterone receptor-positive breast cancer.
Clinical Breast Cancer.
10:275-280.
2010
|
|
| 2010
|
Effects of Bladder Distension on Organs at Risk in 3D Image-Based Planning of Intracavitary Brachytherapy for Cervical Cancer
2010
|
|
| 2008
|
Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical Cancer
2008
|
|
| 2008
|
An imrt technique to increase therapeutic ratio of breast irradiation in patients with early-stage left breast cancer: limiting second malignancies.
Medical Dosimetry.
33:71-77.
2008
|
|
| 2007
|
In Reply To Dr. Heyman et al.
2007
|
|
| 2007
|
A Dosimetric Comparison of Electronic Compensation, Conventional Intensity Modulated Radiotherapy, and Tomotherapy in Patients With Early-Stage Carcinoma of the Left Breast
2007
|
|
| 2007
|
Anemia correction in malignancy management: Threat or opportunity?.
Gynecologic Oncology.
105:517-529.
2007
|
|
| 2006
|
An IMRT technique to increase therapeutic ratio of breast irradiation in patients with early stage left breast cancer: Limiting second malignancies..
Journal of Clinical Oncology.
24:10791.
2006
|
|
| 2006
|
Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Brachytherapy.
5:49-55.
2006
|
|
| 2005
|
Simultaneous optimization of sequential IMRT plans.
Medical Physics.
32:3257-3266.
2005
|
|
| 2004
|
IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk
2004
|
|
| 2004
|
The role of amifostine in the treatment of carcinoma of the uterine cervix: An update of RTOG-0116 and review of future directions.
Seminars in Oncology.
31:37-41.
2004
|
|
| 2002
|
Epidermal growth factor receptor as a therapeutic target in head and neck cancer.
Seminars in Radiation Oncology.
12:11-20.
2002
|
|
| 2000
|
Carcinoma of the male breast..
Current Treatment Options in Oncology.
1:221-227.
2000
|
|
| 1997
|
Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? Long-term experience at a single institution
1997
|
|
